Daniel Raskas Danaher Corp (DHR) insider trading activity

Daniel Raskas is SVP - Corporate Development of DANAHER CORP . Currently has a direct ownership of 23,595 shares of DHR, which is worth approximately $5.5 Million. The most recent transaction as insider was on Jul 25, 2024, when has been sold 14,507 shares (Common Stock) at a price of $270.51 per share, resulting in proceeds of $3,924,288. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.6K

0% 3M change

38.37% 12M change

Total Value Held $5.5 Million

Daniel Raskas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 25 2024	SELL Open market or private sale	$3,924,288 $270.51 p/Share	14,507 Reduced 38.07%	23,595 Common Stock
Feb 26 2024	SELL Bona fide gift	-	591 Reduced 1.53%	38,102 Common Stock
Feb 26 2024	SELL Open market or private sale	$5,986,764 $252.0 p/Share	23,757 Reduced 38.41%	38,102 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	$1,389,309 $58.48 p/Share	23,757 Added 27.75%	61,859 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	3,471 Added 8.23%	38,693 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$1,466,857 $245.13 p/Share	5,984 Reduced 14.52%	35,222 Common Stock
Jul 28 2023	SELL Bona fide gift	-	385 Reduced 1.0%	38,288 Common Stock
Jul 28 2023	SELL Open market or private sale	$2,922,668 $260.65 p/Share	11,213 Reduced 22.65%	38,288 Common Stock
Jul 28 2023	BUY Exercise of conversion of derivative security	$635,777 $56.7 p/Share	11,213 Added 18.47%	49,501 Common Stock
May 31 2023	SELL Open market or private sale	$4,535,039 $228.5 p/Share	19,847 Reduced 33.91%	38,673 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	$1,149,141 $57.9 p/Share	19,847 Added 25.33%	58,520 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$127,051 $249.12 p/Share	510 Reduced 1.3%	38,673 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	10,440 Added 21.04%	39,183 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$665,005 $267.5 p/Share	2,486 Reduced 7.96%	28,743 Common Stock
Nov 04 2022	SELL Bona fide gift	-	412 Reduced 1.3%	31,229 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$269,931 $271.56 p/Share	994 Reduced 3.05%	31,641 Common Stock
Feb 23 2022	BUY Grant, award, or other acquisition	-	12,750 Added 28.09%	32,635 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$677,717 $287.29 p/Share	2,359 Reduced 10.61%	19,885 Common Stock
Nov 30 2021	SELL Open market or private sale	$4,007,844 $326.0 p/Share	12,294 Reduced 35.6%	22,244 Common Stock
Nov 30 2021	BUY Exercise of conversion of derivative security	$567,122 $46.13 p/Share	12,294 Added 26.25%	34,538 Common Stock
Nov 26 2021	SELL Open market or private sale	$4,001,559 $325.33 p/Share	12,300 Reduced 35.29%	22,550 Common Stock
Nov 26 2021	BUY Exercise of conversion of derivative security	$567,399 $46.13 p/Share	12,300 Added 26.09%	34,850 Common Stock
Aug 31 2021	SELL Bona fide gift	-	306 Reduced 1.36%	22,244 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$372,856 $223.0 p/Share	1,672 Reduced 6.9%	22,550 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	$1,484,126 $223.85 p/Share	6,630 Added 21.49%	24,222 Common Stock

Also insider at

NVST

Envista Holdings Corp Healthcare

Director

Daniel Raskas

SVP - Corporate Development

Washington, DC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DHR shares.

Notify only if

Value

Insider Trading

Get notified when an Danaher Corp insider buys or sells DHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to DANAHER CORP

Track Activities on DHR

Account